Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Exact Sciences Cor (EXAS)

Exact Sciences Cor (EXAS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,358,975
  • Shares Outstanding, K 185,755
  • Annual Sales, $ 2,759 M
  • Annual Income, $ -1,029 M
  • EBIT $ -179 M
  • EBITDA $ 905 M
  • 60-Month Beta 1.25
  • Price/Sales 2.90
  • Price/Cash Flow 7.64
  • Price/Book 3.32

Options Overview Details

View History
  • Implied Volatility 50.14% ( -1.86%)
  • Historical Volatility 38.87%
  • IV Percentile 27%
  • IV Rank 15.55%
  • IV High 92.38% on 03/18/24
  • IV Low 42.36% on 09/03/24
  • Put/Call Vol Ratio 1.24
  • Today's Volume 637
  • Volume Avg (30-Day) 2,171
  • Put/Call OI Ratio 0.65
  • Today's Open Interest 44,026
  • Open Int (30-Day) 43,852

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 24 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.35
  • Number of Estimates 5
  • High Estimate -0.06
  • Low Estimate -0.70
  • Prior Year -0.50
  • Growth Rate Est. (year over year) +30.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
42.06 +7.42%
on 03/13/25
51.91 -12.96%
on 02/24/25
-4.13 (-8.38%)
since 02/14/25
3-Month
42.06 +7.42%
on 03/13/25
60.88 -25.79%
on 01/13/25
-15.19 (-25.16%)
since 12/17/24
52-Week
40.62 +11.22%
on 06/25/24
79.62 -43.26%
on 04/02/24
-12.53 (-21.71%)
since 03/15/24

Most Recent Stories

More News
1 Stock Under $50 to Target This Week and 2 to Turn Down

1 Stock Under $50 to Target This Week and 2 to Turn Down

SHOO : 25.76 (+1.82%)
EXAS : 45.18 (+0.40%)
IAC : 47.12 (+5.75%)
ReShape Lifesciences, Allarity, Exact Sciences, CVS, AbbVie: 5 Health Care Stocks That Led Retail Message Growth Last Week

Speculation over an impending reverse merger, a Phase 2 trial announcement, comments about upcoming cancer screening tests, a Medicare business deal, and an obesity drug partnership sparked buzz among...

CVS : 66.65 (+1.48%)
EXAS : 45.18 (+0.40%)
ABBV : 214.47 (+1.27%)
RSLS : 0.6300 (-0.87%)
ALLR : 0.9280 (-3.19%)
Natera (NTRA) Q4 Earnings: What To Expect

Natera (NTRA) Q4 Earnings: What To Expect

NTRA : 149.25 (+0.69%)
EXAS : 45.18 (+0.40%)
REGN : 678.42 (+1.73%)
2 Stocks Down 59% and 34% to Buy and Hold

Warren Buffett, arguably the greatest investor of all time, once said it is wise for investors to be fearful when others are greedy. One way to apply this advice from the Oracle of Omaha is to look at...

GH : 42.90 (+0.02%)
ETSY : 46.29 (+1.40%)
EXAS : 45.18 (+0.40%)
ORCL : 154.01 (+3.18%)
Why Exact Sciences (EXAS) Shares Are Trading Lower Today

Why Exact Sciences (EXAS) Shares Are Trading Lower Today

EXAS : 45.18 (+0.40%)
Exact Sciences (EXAS) Q4 2024 Earnings Call Transcript

EXAS earnings call for the period ending December 31, 2024.

EXAS : 45.18 (+0.40%)
Exact Sciences: Q4 Earnings Snapshot

Exact Sciences: Q4 Earnings Snapshot

EXAS : 45.18 (+0.40%)
Exact Sciences’s (NASDAQ:EXAS) Q4: Beats On Revenue

Exact Sciences’s (NASDAQ:EXAS) Q4: Beats On Revenue

EXAS : 45.18 (+0.40%)
Exact Sciences (EXAS) Reports Earnings Tomorrow: What To Expect

Exact Sciences (EXAS) Reports Earnings Tomorrow: What To Expect

EXAS : 45.18 (+0.40%)
INCY : 62.01 (-8.62%)
REGN : 678.42 (+1.73%)
2 Healthcare Stocks to Buy Hand Over Fist in January

Stocks tend to perform well in January, but that's not a good reason to invest this month. Strong returns aren't made in a single 30-day period. Instead, as long-term investors know, the key is to hold...

EXAS : 45.18 (+0.40%)
DXCM : 71.35 (+0.93%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

Exact Sciences Corporation is a molecular diagnostics company focused on the early detection and prevention of some of the deadliest forms of cancer. The company has developed an accurate, non-invasive, patient-friendly screening test called Cologuard for the early detection of colorectal cancer and...

See More

Key Turning Points

3rd Resistance Point 46.80
2nd Resistance Point 46.38
1st Resistance Point 45.78
Last Price 45.18
1st Support Level 44.76
2nd Support Level 44.34
3rd Support Level 43.74

See More

52-Week High 79.62
Fibonacci 61.8% 64.72
Fibonacci 50% 60.12
Fibonacci 38.2% 55.52
Last Price 45.18
52-Week Low 40.62

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar